nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—GALR3—eye—age related macular degeneration	0.0773	0.196	CbGeAlD
Dinoprost Tromethamine—GALR3—retina—age related macular degeneration	0.0766	0.194	CbGeAlD
Dinoprost Tromethamine—SLC22A8—optic choroid—age related macular degeneration	0.0678	0.172	CbGeAlD
Dinoprost Tromethamine—PTGER3—connective tissue—age related macular degeneration	0.0339	0.0861	CbGeAlD
Dinoprost Tromethamine—HPGDS—connective tissue—age related macular degeneration	0.0293	0.0744	CbGeAlD
Dinoprost Tromethamine—PTGFR—eye—age related macular degeneration	0.0282	0.0714	CbGeAlD
Dinoprost Tromethamine—PTGIR—connective tissue—age related macular degeneration	0.0239	0.0607	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—retina—age related macular degeneration	0.0217	0.0551	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—eye—age related macular degeneration	0.0217	0.055	CbGeAlD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.0141	0.0233	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—eye—age related macular degeneration	0.0136	0.0346	CbGeAlD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.013	0.0215	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—RHO—age related macular degeneration	0.0122	0.0201	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0119	0.0196	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0113	0.0187	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0108	0.0179	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0108	0.0178	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0103	0.0169	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00968	0.016	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00904	0.0149	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00876	0.0145	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—RHO—age related macular degeneration	0.00852	0.0141	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.0079	0.013	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—F13B—age related macular degeneration	0.00775	0.0128	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00764	0.0126	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00755	0.0125	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00751	0.0124	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—RHO—age related macular degeneration	0.00737	0.0122	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SERPING1—age related macular degeneration	0.00729	0.012	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00728	0.012	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00686	0.0113	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00677	0.0112	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—RAD51B—age related macular degeneration	0.00632	0.0104	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.00629	0.0104	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.0062	0.0102	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00617	0.0102	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00591	0.00976	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—SLC16A8—age related macular degeneration	0.00588	0.0097	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00585	0.00965	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00579	0.00955	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00579	0.00955	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—RHO—age related macular degeneration	0.00572	0.00944	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0055	0.00907	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0055	0.00907	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00539	0.00889	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00521	0.0086	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00521	0.0086	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—RHO—age related macular degeneration	0.00516	0.00851	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—F13B—age related macular degeneration	0.00512	0.00845	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00506	0.00836	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00496	0.00818	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00496	0.00818	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00489	0.00807	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SERPING1—age related macular degeneration	0.00481	0.00794	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—C3—age related macular degeneration	0.00467	0.0077	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—RAD51B—age related macular degeneration	0.00417	0.00689	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—RHO—age related macular degeneration	0.00417	0.00688	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00411	0.00678	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—G alpha (i) signalling events—C3—age related macular degeneration	0.00394	0.0065	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—SLC16A8—age related macular degeneration	0.00388	0.0064	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—RHO—age related macular degeneration	0.00386	0.00636	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—RHO—age related macular degeneration	0.00378	0.00625	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—RHO—age related macular degeneration	0.00377	0.00623	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—RHO—age related macular degeneration	0.00377	0.00623	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—NMNAT1—age related macular degeneration	0.00371	0.00612	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—CCL2—age related macular degeneration	0.00365	0.00603	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RDH8—age related macular degeneration	0.00365	0.00602	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00343	0.00566	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00338	0.00559	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—ELOVL4—age related macular degeneration	0.00324	0.00535	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—RHO—age related macular degeneration	0.00323	0.00533	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RPE65—age related macular degeneration	0.00319	0.00526	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00313	0.00517	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00307	0.00507	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.003	0.00496	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—RHO—age related macular degeneration	0.00293	0.00484	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—RHO—age related macular degeneration	0.00291	0.00481	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.0029	0.00478	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00286	0.00472	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RDH8—age related macular degeneration	0.00283	0.00467	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00279	0.0046	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—G alpha (i) signalling events—C3—age related macular degeneration	0.00275	0.00455	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00274	0.00452	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00274	0.00452	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00272	0.00448	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—RHO—age related macular degeneration	0.00265	0.00437	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—SLC16A8—age related macular degeneration	0.00261	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00257	0.00425	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—ABCA4—age related macular degeneration	0.00257	0.00424	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RDH8—age related macular degeneration	0.00255	0.00421	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00248	0.0041	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00248	0.0041	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RPE65—age related macular degeneration	0.00247	0.00408	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00245	0.00404	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00243	0.00401	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—C3—age related macular degeneration	0.00238	0.00393	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00234	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—RHO—age related macular degeneration	0.00224	0.00369	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RPE65—age related macular degeneration	0.00223	0.00368	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00219	0.00361	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—RHO—age related macular degeneration	0.00218	0.0036	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—RHO—age related macular degeneration	0.00213	0.00352	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—RHO—age related macular degeneration	0.00213	0.00352	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00209	0.00345	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00209	0.00345	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—ABCA4—age related macular degeneration	0.00199	0.00329	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00199	0.00328	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—RHO—age related macular degeneration	0.00198	0.00327	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00196	0.00323	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—RHO—age related macular degeneration	0.00194	0.0032	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—RHO—age related macular degeneration	0.00194	0.0032	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RDH8—age related macular degeneration	0.00191	0.00315	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0019	0.00314	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RDH8—age related macular degeneration	0.00187	0.00308	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RDH8—age related macular degeneration	0.00187	0.00308	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—CCL2—age related macular degeneration	0.00187	0.00308	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—C3—age related macular degeneration	0.00185	0.00305	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—ABCA4—age related macular degeneration	0.0018	0.00297	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—CD36—age related macular degeneration	0.00174	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00174	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00174	0.00288	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00174	0.00287	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—RHO—age related macular degeneration	0.00173	0.00286	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00171	0.00283	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—C3—age related macular degeneration	0.00167	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RPE65—age related macular degeneration	0.00167	0.00275	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00164	0.0027	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RPE65—age related macular degeneration	0.00163	0.00269	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RPE65—age related macular degeneration	0.00163	0.00269	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00163	0.00269	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00161	0.00266	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0016	0.00265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0016	0.00265	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—RHO—age related macular degeneration	0.00156	0.00258	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00154	0.00254	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00145	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00145	0.0024	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—CCL2—age related macular degeneration	0.00145	0.00239	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00135	0.00223	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—C3—age related macular degeneration	0.00135	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—ABCA4—age related macular degeneration	0.00134	0.00222	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—LIPC—age related macular degeneration	0.00134	0.00221	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—ABCA4—age related macular degeneration	0.00132	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—ABCA4—age related macular degeneration	0.00132	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—CCL2—age related macular degeneration	0.0013	0.00215	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CETP—age related macular degeneration	0.00129	0.00213	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00128	0.00211	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—TGFBR1—age related macular degeneration	0.00125	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00125	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00125	0.00207	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—C3—age related macular degeneration	0.00125	0.00206	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00123	0.00203	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—C3—age related macular degeneration	0.00122	0.00202	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—C3—age related macular degeneration	0.00122	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—C3—age related macular degeneration	0.00122	0.00201	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—RHO—age related macular degeneration	0.00117	0.00193	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—CD36—age related macular degeneration	0.00115	0.0019	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—RHO—age related macular degeneration	0.00114	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—RHO—age related macular degeneration	0.00114	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—SQSTM1—age related macular degeneration	0.00114	0.00188	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—C3—age related macular degeneration	0.00104	0.00172	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00103	0.0017	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—CCL2—age related macular degeneration	0.000976	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—TGFBR1—age related macular degeneration	0.000973	0.00161	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—NMNAT1—age related macular degeneration	0.000966	0.00159	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—CCL2—age related macular degeneration	0.000957	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—CCL2—age related macular degeneration	0.000955	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—CCL2—age related macular degeneration	0.000955	0.00158	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—C3—age related macular degeneration	0.000949	0.00157	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—C3—age related macular degeneration	0.000942	0.00156	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—SQSTM1—age related macular degeneration	0.000882	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000878	0.00145	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000861	0.00142	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—C3—age related macular degeneration	0.000856	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—ELOVL4—age related macular degeneration	0.000844	0.00139	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Hemostasis—VEGFA—age related macular degeneration	0.000831	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000796	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—CD36—age related macular degeneration	0.000776	0.00128	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—CCL2—age related macular degeneration	0.000742	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—C3—age related macular degeneration	0.000723	0.00119	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000718	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—C3—age related macular degeneration	0.000705	0.00116	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—C3—age related macular degeneration	0.00069	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—C3—age related macular degeneration	0.00069	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Metabolism—APOE—age related macular degeneration	0.000684	0.00113	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—SLC16A8—age related macular degeneration	0.000681	0.00112	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—APOE—age related macular degeneration	0.000673	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—CCL2—age related macular degeneration	0.00067	0.00111	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KDR—age related macular degeneration	0.000659	0.00109	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000656	0.00108	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—TGFBR1—age related macular degeneration	0.000642	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000642	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—C3—age related macular degeneration	0.00064	0.00106	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—C3—age related macular degeneration	0.000626	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—C3—age related macular degeneration	0.000626	0.00103	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—SQSTM1—age related macular degeneration	0.000595	0.000982	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—SQSTM1—age related macular degeneration	0.000582	0.000961	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000582	0.000961	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—CCL2—age related macular degeneration	0.000566	0.000933	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—C3—age related macular degeneration	0.00056	0.000925	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Hemostasis—VEGFA—age related macular degeneration	0.000548	0.000905	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—APOE—age related macular degeneration	0.000522	0.000861	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KDR—age related macular degeneration	0.000511	0.000844	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—C3—age related macular degeneration	0.000505	0.000834	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—CCL2—age related macular degeneration	0.000501	0.000826	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—CCL2—age related macular degeneration	0.00049	0.000809	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—CCL2—age related macular degeneration	0.00049	0.000809	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—APOE—age related macular degeneration	0.000471	0.000777	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KDR—age related macular degeneration	0.000461	0.000761	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—CCL2—age related macular degeneration	0.000439	0.000724	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—CCL2—age related macular degeneration	0.000396	0.000653	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—C3—age related macular degeneration	0.000378	0.000624	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—C3—age related macular degeneration	0.00037	0.000611	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—C3—age related macular degeneration	0.00037	0.000611	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—VEGFA—age related macular degeneration	0.000363	0.000599	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—APOE—age related macular degeneration	0.000352	0.000581	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—LIPC—age related macular degeneration	0.000348	0.000575	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KDR—age related macular degeneration	0.000345	0.000569	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—APOE—age related macular degeneration	0.000344	0.000568	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—APOE—age related macular degeneration	0.000344	0.000568	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KDR—age related macular degeneration	0.000337	0.000557	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KDR—age related macular degeneration	0.000337	0.000557	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CETP—age related macular degeneration	0.000336	0.000555	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—CCL2—age related macular degeneration	0.000296	0.000488	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—CCL2—age related macular degeneration	0.00029	0.000478	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—CCL2—age related macular degeneration	0.00029	0.000478	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—VEGFA—age related macular degeneration	0.000282	0.000465	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—VEGFA—age related macular degeneration	0.000254	0.000419	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—CD36—age related macular degeneration	0.000202	0.000333	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—VEGFA—age related macular degeneration	0.00019	0.000313	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—VEGFA—age related macular degeneration	0.000186	0.000307	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—VEGFA—age related macular degeneration	0.000186	0.000307	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—APOE—age related macular degeneration	0.000178	0.000294	CbGpPWpGaD
